Antenatal insulin therapy in gestational diabetes mellitus: validation of the new Brugmann scores.

Dominique A BadrChirine KassemAndrew CarlinOana DobrescuLaura IconaruFelicia BaleanuGeorgiana Cristina TaujanJacques C Jani

Published in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2022)

Both Brugmann FPG and OGTT scores may be useful to stratify patients with GDM according to their need for AIT. Future studies should be conducted to prospectively validate these scores, and to examine whether or not using oral anti-hyperglycemic agents in a high-risk group may decrease the need for AIT.

Keyphrases

pregnant women
type diabetes
preterm birth
glycemic control
case control
mesenchymal stem cells
insulin resistance
bone marrow